NIATx Buprenorphine Implementation Toolkit
Provides an overview of how organizations can use NIATx practices and tools to implement or improve a buprenorphine treatment program.
For the prevention of and response to diversion (i.e. selling or sharing of medications) or misuse (i.e. taking medication in a manner other than prescribed) of medications to treat opioid use disorder.
Provides an overview of how organizations can use NIATx practices and tools to implement or improve a buprenorphine treatment program.
These are slides from a webinar which provided an overview of how drug diversion is a significant risk for patients and institutions and addresses why institutions should have a program in place to detect diversion.